SBIR/STTR Research Award

Biocompatible retinal prosthesis based on a conjugated polymer photoactive layer

Award identifier bef623b59fdc35754d3f9d3cb563915512fb3cfdc3998ca80273fa6a0a48733eAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$310,154

Program and phase

SBIR · Phase I

Award year

2015

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
LYNNTECH INC.
Proposal award date
2015-09-30
Contract end date
2016-08-31
UEI
PMVAL8J63516
Solicitation number
PA14-071
Topic code
N

Research abstract

DESCRIPTION provided by applicant This proposal is in response to a specific approved topic area as defined by the NEI in Appendix A National Institutes of Health SBA Approved SBIR STTR Topics for Awards over Statutory Budget Limitations from the PHS Omnibus Solicitation for SBIR STTR Grant Applications This Phase I feasibility study is an advanced technology project with a clearly identified product that will result in a clinically relevant treatment for retinal disease The award period and amount requested are guided by project needs and are in compliance with issued guidelines Age related macular degeneration and retinitis pigmentosa are cause millions of cases of blindness due to retinal degradation Treatment options such as transplants vitamin supplements or pharmaceuticals are available but they may only serve to slow the disease or be of limited efficacy New treatment options such as gene or stem cell therapy are of only limited value due to technical difficulties or questionable safety Prosthetic options are promising and are undergoing clinical evaluation There are several drawbacks with current prosthetic models including limited resolution excessive external hardware and biocompatibility problems in part due to excessive heat or current generation Conjugated polymers however have been shown to produce a spatially localized response from explanted retinas using only illumination as a power source The advantages over previously established retinal prosthetics include little to no heat generation improved biocompatibility and no need for external hardware or a multi electrode array For better biocompatibility and overall functionality we propose the development of alternative photoactive materials that are better suited to the eyeandapos s own biology We propose to develop prosthetics consisting of a hydrogel substrate coated with an active layer of conjugated polymer block copolymer These materials are improvements upon the current research in conjugated polymers for retinal activation in that they are all soft materials that enable the diffusion of nutrients through a gel Our specific aims are designed to demonstrate feasibility in vitro biocompatibility stability and ability to activate retinal neurons in explanted rat retinas Thes aims include the formulation of conjugated polymer hydrogel prostheses determine in vitro biocompatibility and photochemical stability and demonstrate prosthesis operation ex vivo with explanted photoreceptor degenerate rat retinas Successful completion of these aims will yield suitable candidates to be used in a retinal prosthesis We will characterize polymers fo their photoelectrochemical activity and ability to diffuse nutrients We will also assess in vitro biocompatibility and stability by evaluating the viability and histology of cells cultured on our materials under illumination as they would be in operation We will assess their ability to stimulate explanted animal retinas by evaluating activity threshold range frequency and spatial localization A revision of form factor such as this could precipitate a paradigm shift in the approach taken to develop prosthetic technologies as well as push boundaries in light activated neural interfaces PUBLIC HEALTH RELEVANCE This project will demonstrate feasibility to use conjugated polymers as photoactive materials in retinal prostheses Flexible substrates and conjugated polymers will be selected for their ability to diffuse nutrients biocompatibility and ability to activate retinal neurons The anticipated benefits of our research are simple to make prosthetics that are minimally invasive and comfortable

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Research funding history

1,079 SBIR/STTR records share this UEI (1988–2025). Reported award amounts total $327,411,388. Reported amounts are not federal obligations.

Phases: Phase I, Phase II, Phase II – Direct to Phase II

Agencies: Department of Defense, Department of Health and Human Services, National Aeronautics and Space Administration, Department of Energy, National Science Foundation, Environmental Protection Agency

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.